politics
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
Why this matters: political developments that affect policy direction and public trust.
The Food and Drug Administration's (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) for the FD
Read full story on The Hill → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop